Form 10-Q CATALYST PHARMACEUTICALS For: Mar 31
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- Tech stocks pull Wall Street lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
Catyalyst Pharma (CPRX) Reports In-Line Q1 Loss
May 10, 2016 4:57 PM EDTCatyalyst Pharma (NASDAQ: CPRX) reported Q1 EPS of ($0.07), in-line with the analyst estimate of ($0.07).
Upcoming 2016 Milestones
Collaboratively working with the FDA to finalize a regulatory path forward for FirdapseInitiate the confirmatory Phase 3 trial for... More